# Virtual Vision Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/virtual-vision-health

- Industry: Medical Devices & Equipment
- Headquarters: Miami, US
- Website: www.virtualvision.health/
- Total disclosed funding: $0.5M
- Latest round: Seed (Sep 15, 2025)
- Investors on record: 1

## About

Based in the US, Virtual Vision Health offers innovative visual field testing solutions, utilizing advanced technology to enhance the efficiency and accuracy of eye care diagnostics for healthcare professionals.Virtual Vision Health specializes in innovative visual field testing solutions. Founded in 2020, the company is headquartered in Miami, US. The company raised USD 500,000 in Seed funding on September 15, 2025, from Govo Venture Partners, marking its first investment round and total amount raised. The founder's history and prior ventures are not publicly available.Virtual Vision specializes in providing innovative visual field testing solutions through its flagship product, the Virtual Eye device. This state-of-the-art technology employs virtual reality to conduct visual field tests, offering a portable and user-friendly alternative to traditional automated perimetry (SAP). The device is designed to streamline the testing process, allowing practitioners to set up tests in under two minutes, with audio instructions guiding patients throughout the examination. This functionality enhances patient experience and reduces the need for staff supervision during tests. Virtual Vision's target market includes ophthalmology clinics, hospitals, and eye care professionals across the United States and internationally, focusing on regions where advancements in ophthalmic technology are in demand, such as North America, Europe, and parts of Asia.Virtual Vision generates revenue primarily through direct sales of its Virtual Eye device to medical practices and healthcare institutions. The company operates on a B2B model, catering to ophthalmologists and optometrists who require efficient and accurate visual field testing solutions. Clients typically purchase the device outright and may also subscribe to additional software services that enhance the functionality of the Virtual Eye system. This includes cloud-based features for data management and reporting, ensuring seamless integration with existing electronic medical records (EMR) systems. The pricing plans associated with these products reflect the value of the technology and its ability to improve testing efficiency, accuracy, and patient outcomes in clinical settings.In September 2025, Virtual Vision Health plans to utilize the raised USD 500,000 in Seed funding to expand its sales team and meet regulatory requirements for entering new international markets. The company aims to introduce new products designed to enhance visual testing capabilities while targeting expansion into markets in Europe and Asia by 2026.

## Funding rounds

- Seed, Sep 15, 2025, $0.5M — Govo Venture Partners

## Investors

- Govo Venture Partners (https://capitalatlas.ai/funds/govo-venture-partners) — Seed